
Treatment guidelines from the FDA limit the ultrasonic ablation of uterine fibroids to 50% of the lesion mass, as seen and targeted with MRI, a limitation that has raised doubts in the medical community about whether the treatment can be effective. But Dr. Phyllis Gee, medical director of the North Texas Uterine Fibroid Institute in Plano, says physicians need not be concerned about the efficacy or long-lasting effect of this treatment.























